Hot topic—News ｜ Bio@Taipei

News

Charles River launches program for animal testing alternatives

2024.04.18

CAR T Cell Therapies Last Longer, Work Better with FOXO1 Protein

2024.04.16

AACR: Verastem, Quanta and Frontier demonstrate KRAS inhibitors' potential in preclinical data

2024.04.11

Microbiome Pathway Implicated in Chronic Kidney Disease

2024.04.09

In major step toward the clinic, Ring’s human viral vector delivers gene therapy to eyes of mice

2024.04.04

Mouth microbe on the move may drive colorectal cancer progression

2024.04.01

Mustang Bio, City of Hope CAR-T therapy extends survival in phase 1 glioblastoma trial

2024.03.27

BioCardia rejigs phase 3 heart failure data to find a path forward for cell therapy

2024.03.25

Protein Holograms Provide Molecular Level Detail

2024.03.22

The top 10 pharma R&D budgets for 2023

2024.03.20

ReciBioPharm Partners with GeneVentiv on AAV-based Gene Therapy for the Treatment of Hemophilia

2024.03.18

AI Detects Cancer via DNA Repeats in Liquid Biopsies

2024.03.14

Overactive Gene Linked to Heart Defects in Down Syndrome

2024.03.12

GE HealthCare, Vanderbilt AI models predict immunotherapy responses among cancer patients

2024.03.07

New ALS Treatments Face Regulatory Uncertainty

2024.03.04

Total 13

Total 13

Back to top